Comparison of two molecular methods for detecting toxigenic Clostridium difficile

Area of Science:

• Clinical Microbiology
• Infectious Diseases
• Molecular Diagnostics

Background:

• Clostridium difficile infection (CDI) is a leading cause of hospital-acquired diarrhea.
• Diagnostic approaches for CDI have evolved from traditional methods to advanced molecular techniques.
• Accurate and rapid detection of C. difficile is crucial for effective patient management.

Purpose of the Study:

• To evaluate and compare the diagnostic performance of two molecular assays: Meridian Illumigene™ and AdvanSure CD real-time PCR.
• To assess the accuracy of these molecular methods against a toxigenic culture reference standard.
• To determine the sensitivity, specificity, and predictive values of each assay in detecting C. difficile.

Main Methods:

• A study involving 203 stool samples was conducted at a tertiary university hospital.
• Samples were analyzed using conventional culture, VIDAS C. difficile toxin assay, AdvanSure CD real-time PCR, and Meridian Illumigene™.
• Molecular assays targeted specific toxin genes (tcdA, tcdB) for C. difficile identification.

Main Results:

• A high concordance rate of 97.0% was observed between the two molecular assays.
• Meridian Illumigene™ demonstrated sensitivity of 92.3% and specificity of 99.4%.
• AdvanSure CD real-time PCR showed sensitivity of 84.6% and specificity of 98.3%.

Conclusions:

• Both Meridian Illumigene™ and AdvanSure CD real-time PCR are effective molecular diagnostic tools for C. difficile.
• The performance of these assays is comparable to toxigenic culture, with slight variations in sensitivity and specificity.
• These molecular methods provide reliable options for diagnosing C. difficile infections in clinical settings.